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Editorials
Simple statements of risks and benefits may not reveal the complexity of human responses 
to research participation
IN THIS ISSUE OF THE JOURNAL, Scott and colleagues
(page 507) report on a retrospective study of family mem-
bers’ experience of participation in a previous study follow-
ing their child’s diagnosis with Ewing’s sarcoma.1 The
research is important because it casts empirical light on an
ethical issue often debated in human research ethics com-
mittee meetings: how does research affect those who partic-
ipate in it? Ethics committees can be very cautious about
granting approval for research into sensitive areas because of
concern about the impact on research participants.
People participate in research for many reasons. They may
feel an obligation to their doctor, they may not think they
have a choice in the matter, they may hope or believe they
will benefit from the research, or they may just wish to help
others.2-4 Regardless of the reasons research participants
may have for participating, the National Health and Medical
Research Council (NHMRC) guidelines5 make clear that
the primary duty of members of ethics committees is to
attend to the “dignity and wellbeing” of research partici-
pants. Ethics committees focus, above all, on the risk of
harm or discomfort to participants and on the requirement
that participants make a free and informed choice to
participate in research. Committees need to bear in mind
that
In clinical research . . . the risks of participation must be
balanced by the possibility of intended benefits to the
participants. In other research involving humans . . . the
absence of intended benefits to a participant should justly be
balanced by the absence of all but minimal risk.2
However, the data from Scott et al suggest that balancing
risks and benefits is not necessarily a straightforward matter.
How research participants experience risks and benefits can
be rather complex.
First — at least for research into sensitive areas such as
serious and life-threatening illness — participants may find
it painful and distressing to recall past events or articulate
complex emotions. However, doing so in a supportive
environment may actually be beneficial. Scott et al indicate
that the benefits gained by participants in their study came
despite the pain of talking about distressing events. I would
argue that the evidence in their article suggests that some
benefits seemed to accrue to participants because they could
talk about painful experiences. Ethics committees may be
able to separate out the risks and benefits conceptually, but
in people’s experience of taking part in research, as in other
areas of our lives, things are seldom so tidy.
Furthermore, the qualitative data reported imply that an
additional benefit to participants was the opportunity to
learn more about Ewing’s sarcoma. Research participants
often ask questions — about their illness and its treatment,
about the researcher’s opinion of the medical care they are
receiving, or about other treatment alternatives that may be
available. Participating in research can provide extra contact
with “experts”, which may be of benefit to participants.The
question arises, “Is it ethical to inform prospective research
participants of such benefits?”. Members of ethics commit-
tees may not be comfortable with answering “yes” to this
question, because they are likely to be worried about the
coercive effect of such information. They may also be
concerned about other factors that come into play when the
researchers’ role is extended to include answering partici-
pants’ questions. They may be apprehensive about the
possible effects on the scientific integrity of the research
itself; they may believe that research staff are not the best
people to answer questions about the participant’s condi-
tion; or they may be concerned about role confusion for
researchers when they also provide advice.6 In addition to
considering how researchers should respond to requests for
information, it is important to consider why researchers are
being placed in this position at all. It is an indictment of our
healthcare system that patients may think they need to take
part in research in order to have their needs for information
and reassurance met.
The study by Scott et al also raises the tricky question of
the role of altruism in research participation. Nearly all of
the study participants felt that their involvement would
benefit others. Researchers may encourage such beliefs,
often in the context of explaining that they can not guaran-
tee that the research will benefit the participants themselves.
The possibility of benefit to others is sometimes all that can
be held out as an incentive for potential participants. Even
here, however, things are not that simple. Feeling that others
are helped by our involvement in research can be of benefit
to us, as concern for our own interests and concern for
others’ interests are actually closely intertwined.7,8 Some-
times we act altruistically because we enjoy the feeling of
being an altruistic person and the positive response it
engenders in others. In a sense, our self-interested choices
can be re-interpreted as altruistic, and vice versa. In Scott
and colleagues’ study, feeling that others might benefit from
their involvement perhaps offered the participants a way to
make sense of difficult and otherwise inexplicable events.
Finally, the whole issue of risks, benefits and altruism is
further complicated by questions about whose notions of
risks, benefits and altruism are to count. Ethics committee
members, research participants and researchers are all likely
to offer different interpretations of these concepts in specific
situations. For example, should ethics committees intervene
if research participants choose to believe their involvement
will help other people like them if, in fact, there is little
evidence that this will occur? Can committee members or
researchers accurately judge the risks and benefits of
research for a participant, or should the emphasis be
principally on facilitating choice? Human emotions and
ethics are complicated, and simple statements of risks,
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benefits and altruistic intent are unlikely to reveal the
complexity of the situation.
What are ethics committees, researchers and participants
(potential and actual) to make of all this? They should, at
least, recognise that guidelines are only that, and can never
substitute for careful and nuanced consideration of the
meanings of terms such as “risk” and “benefit”. The
NHMRC’s Commentary on the national statement on ethical
conduct in research involving humans, released this year,
provides something of a roadmap in this area.9 But commit-
tees will still need skills, knowledge, time and resources to
consider these issues thoughtfully. While skills and knowl-
edge may not be in doubt, we know that many committees
lack the time and resources needed to do justice to these
thorny issues.10
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